Key result
Adipocyte-derived miR-30e-5p was significantly upregulated in obese humans with coronary artery disease, predicting CAD with an AUC of 0.81, and promoted atherosclerosis by targeting SLC7A11 in endothelial cells.
Why the study?
Whether an endocrine-like link between adipose-derived miR-30e-5p and SLC7A11 in vascular endothelium leads to obesity-caused atherosclerosis is unknown.
Does the adipose-derived miR-30e-5p-SLC7A11 axis increase atherosclerosis susceptibility in obesity, and does its antagonism prevent it?
Does the adipose-derived miR-30e-5p-SLC7A11 axis increase atherosclerosis susceptibility in obesity, and does its antagonism prevent it?
Effect estimate: AUC 0.81
This study identifies an endocrine-like axis where adipose-derived miR-30e-5p downregulates SLC7A11 in endothelial cells, driving obesity-related atherosclerosis and offering a potential therapeutic target.
miR-30e-5p antagonism merits exploration as an axis in obesity-related atherosclerosis; animal data leave open human translation and clinical relevance.
Background With obesity as a risk factor for atherosclerotic disease, recent research suggests that adipose tissue in obese animal models and humans can generate endocrine-like molecules that affect arterial health later on. Previous studies showed that microRNA-30e (miR-30e) level is elevated in atherosclerosis and solute carrier family 7 member 11 (SLC7A11), a cystine/glutamate transporter, is involved in atherogenesis. However, whether an endocrine-like link between the adipose-derived miR-30e-5p and SLC7A11 in the vascular endothelium can lead to obesity-caused atherosclerosis is unknown. Methods MiRNA data mining and RT-PCR validations were used to demonstrate the positive association among serum level of miR-30e-5p, obesity, and coronary arterial disease in human patients. Transcriptomics (RNA-seq and single-nucleus RNA-seq), metabolomics, and in silico analysis were used to establish a miR-30e-5p–SLC7A11 regulation of central carbon metabolism, mitochondrial and endothelial cell (EC) function. Mouse models with EC-specific Slc7a11 knockout (EC- Slc7a11 -/- ) and gain or loss of function of miR-30e-5p were used to elucidate the detrimental role of this endocrine-like axis in obesity-related atherosclerosis. Results The level of adipocyte-derived miR-30e-5p was significantly upregulated in obese humans with coronary artery disease and obese and atherosclerotic mice. Via serum exosomes, the adipocyte-generated miR-30e-5p targeted SLC7A11 mRNA in vascular ECs. SLC7A11 deficiency due to miR-30e-5p targeting dysregulated glutamate/cystine metabolism increased glycolysis, reduced oxidative phosphorylation, and impaired mitochondrial function. The EC dysfunction could be rectified by SLC7A11 overexpression or miR-30e-5p antagonism. Exogenously delivered miR-30e-5p phenocopied the increased atherosclerosis in EC- Slc7a11 -/- mice. In contrast, miR-30e-5p antagomir treatment reduced atherosclerosis in Apoe -/- and ob/ob mice. Conclusion Our multi-omics approaches demonstrates that the adipose-derived miR-30e-5p downregulated SLC7A11 mRNA in ECs via tissue crosstalk. The resulting EC dysfunction led to obesity-related atherosclerosis in mice. These findings underscore a causality between obesity and atherosclerosis in the context of cardiovascular-kidney-metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Coronary artery disease and obesity. Elevated adipose-derived miR-30e-5p vs. Healthy controls was evaluated on Probability of coronary artery disease (AUC 0.81). Adipocyte-derived miR-30e-5p was significantly upregulated in obese humans with coronary artery disease, predicting CAD with an AUC of 0.81, and promoted atherosclerosis by targeting SLC7A11 in endothelial cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: